Close Menu

Behind the Scenes

At the US Centers for Disease Control and Prevention's Genomics and Health Impact blog this week, Muin Khoury — who directs the agency's Office of Public Health Genomics — describes "a day in the invisible life of public health genomics." Khoury narrates a hypothetical workday for a fictitious woman, who, like most of the public, he says, does not "realize that public health is at work to help make sure that genomic technologies are use

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.